GLP-1 receptor agonists for primary prevention of breast cancer in high-risk women: A real-world analysis of efficacy and safety.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Mercy Medical Center North Iowa, The University of Texas at San Antonio, Mays Cancer Center at UT Health San Antonio, Texas Tech University, Texas Tech University Health Sciences Center, Jefferson Einstein Philadelphia Hospital, The University of Texas at San Antonio Health Science Center, Mayo Clinic in Florida
Language: English
Topic: Cancer Risks and Factors
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162485319
